A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017
LSD instead of 25I-NBOMe: The revival of LSD? A case report
Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Dinis-Oliveira, R. J. | Drug Metabolism Reviews | 31 January 2017
Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Halberstadt, A. L. | Current Topics in Behavioral Neurosciences | 18 January 2017
Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro
Fonseca, D. A., Guerra, A. F., Carvalho, F., Fernandes, E., Ferreira, L. M., Branco, P. S., ... & Cotrim, M. D. | Cardiovascular Toxicology | 13 January 2017
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015
Heise, C. W., & Brooks, D. E. | Journal of medical toxicology | 28 November 2016
A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction
Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016
Multisystem Organ Failure and Death Resulting From Ingestion of “Molly” (3,4-Methylenedioxymethamphetamine)
Shelton, C. P., & Rosini, J. M. | Journal of Emergency Nursing | 1 September 2015
Cytotoxic Effects of Salvinorin A, A Major Constituent of Salvia divinorum
Martinho, A., M Silva, S., & Gallardo, E. | Medicinal Chemistry | 1 August 2016
Ketamine abuse potential and use disorder
Liu, Y., Lin, D., Wu, B., & Zhou, W. | Brain research bulletin | 31 May 2016
Salvia divinorum: toxicological aspects and analysis in human biological specimens
Margalho, C., Corte-Real, F., López-Rivadulla, M., & Gallardo, E. | Bioanalysis | 9 June 2016
In reply – on the toxicity of ibogaine
Brunt, T. M., & Litjens, R. P. | Clinical toxicology | 31 May 2016
On the toxicity of ibogaine
Yip, L., & Deng, J. F. | Clinical Toxicology | 31 May 2016
Human Pharmacology of Mephedrone in Comparison to MDMA
Papaseit, E., Pérez-Mañá, C., Mateus, J. A., Pujadas, M., Fonseca, F., Torrens, M., ... & Farré, M. | Neuropsychopharmacology | 20 May 2016
Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat
Horsley, R. R., Lhotkova, E., Hajkova, K., Jurasek, B., Kuchar, M., & Palenicek, T. | Brain Research Bulletin | 4 May 2016
Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Rubi, L., Eckert, D., Boehm, S., Hilber, K., & Koenig, X. | Cardiovascular Toxicology | 28 March 2016
Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
Kyzar, E. J., & Kalueff, A. V. | Zebrafish | 22 March 2016
How toxic is ibogaine?
Litjens, R. P., & Brunt, T. M. | Clinical Toxicology | 25 January 2016
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class
Dinger, J., Woods, C., Brandt, S. D., Meyer, M. R., & Maurer, H. H. | Toxicology Letters | 17 November 2015
“Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report
Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. H. | Journal of medical case reports | 31 October 2015
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., & Nemeroff, C. B. | American Journal of Psychiatry | 29 June 2015
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
Pic-Taylor, A., da Motta, L. G., de Morais, J. A., Junior, W. M., Santos, A. D. F. A., Campos, L. A., ... & Caldas, E. D. | Behavioural processes | 3 June 2015
Ketamine-A Narrative Review of Its Uses in Medicine
Radvansky, B. M., Puri, S., Sifonios, A. N., Eloy, J. D., & Le, V. | American Journal of Therapeutics | Apr 24 2015